The text addresses the limitations of existing therapeutic approaches using nanoparticles. It will further provide information for the development of successful cancer nanomedicine therapies.
Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment.
Covers the characteristics of various nanotechnology-based drug delivery systems in detail.
Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction.
Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research.
Highlights smart strategies for improving the clinical impact of cancer nanomedicine.
The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.
